A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy

Affiliations

• ¹ Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Orange, CA.
• ² Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA.
• ³ Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA.
• ⁴ Department of Epidemiology and Biostatistics, University of California, Irvine, Irvine, CA.